Mark P. Valadao
Analyste en capital-investissement chez ORI Capital Investment Advisory Hong Kong Ltd.
Provenance du réseau au premier degré de Mark P. Valadao
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
ORI Capital Investment Advisory Hong Kong Ltd.
 ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital Investment Advisory Hong Kong Ltd (ORI Capital) is a venture capital firm in Hong Kong. The firm was founded by Simone Song in 2015. The firm is headquartered in Hong Kong.
9
| Private Company | Investment Managers | 9 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mark P. Valadao via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Hong Kong | College/University | Undergraduate Degree Graduate Degree | |
| The Chinese University of Hong Kong | College/University | Graduate Degree Graduate Degree | |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| The Hong Kong Polytechnic University | College/University | Graduate Degree | |
Meritech Capital Partners
 Meritech Capital Partners Investment ManagersFinance Meritech Capital Partners (Meritech Capital) is a venture capital firm founded in 1999 by Mike Gorden, Paul Madera and Rob Ward. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
| The Hong Kong University of Science & Technology | College/University | Undergraduate Degree | |
RSM Hong Kong
 RSM Hong Kong Miscellaneous Commercial ServicesCommercial Services RSM Hong Kong operates as an accounting and consulting firms. The firm offers audit and assurance, tax services, risk and corporate advisory services, transaction advisory, financial reporting advisory and technology and management consulting. The company was founded in 1975 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
| COWEN INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| Claremont Graduate University | College/University | Graduate Degree | |
| Fudan University | College/University | Undergraduate Degree | |
| Shanghai Medical College of Fudan University | College/University | Undergraduate Degree | |
| Stanford University | College/University | Corporate Officer/Principal | |
Affyimmune Therapeutics, Inc.
 Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Founder | |
Pillar Biosciences, Inc.
 Pillar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pillar Biosciences, Inc. is a clinical cancer diagnostics company. The firm engages in the creation of precision NGS panels and software solutions. It offers solid tumor panels, blood cancer panels, inherited disease panels, and custom panels. The company was founded by Gang Song and Zhaohui Wang in 2014 and is headquartered in Natick, MA. | Pharmaceuticals: Major | Founder | |
| UW Medicine | College/University | Graduate Degree | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Director/Board Member | |
| Translational Research In Oncology | Corporate Officer/Principal | ||
| CG ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
| UW Graduate School | College/University | Doctorate Degree | |
| New Jersey City University | College/University | Undergraduate Degree | |
| Moffitt Technologies Corp. | Director/Board Member | ||
| FULGENT GENETICS, INC. | Medical/Nursing Services | Director/Board Member | |
| NCI INC | Information Technology Services | Corporate Officer/Principal | |
| University of Michigan | College/University | Corporate Officer/Principal | |
| Hong Kong Baptist University | College/University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 19 |
| Hong Kong | 7 |
| Royaume-Uni | 5 |
| Chine | 3 |
| Canada | 2 |
Sectorielle
| Consumer Services | 14 |
| Health Technology | 8 |
| Commercial Services | 4 |
| Finance | 4 |
| Miscellaneous | 2 |
Opérationnelle
| Director/Board Member | 11 |
| Undergraduate Degree | 8 |
| Corporate Officer/Principal | 7 |
| Graduate Degree | 6 |
| Private Equity Investor | 6 |
Relations les plus connectées
| Insiders | |
|---|---|
| James Mulé | 14 |
| Simone Song | 9 |
| Gang Song | 4 |
| Cathy Choi | 4 |
| Dicky To | 3 |
| Gillian Zhou | 3 |
| Otto Cheung | 2 |
| Edward Tung | 2 |
| Elaine Yang | 1 |
- Bourse
- Insiders
- Mark P. Valadao
- Connexions Sociétés
